MarketInOut Stock Screener Log In | Sign Up

Mega Genomics Ltd

HKSE • Healthcare • Diagnostics & Research • Quote as of 10/30/2026
Mega Genomics Ltd stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeHKSE
Market Capitalization1,572.12 mln
Float125 mln
Earnings Date04/01/2027

EPS

0.15
Overpriced

P / E

47.17
High premium

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-1.09
Manipulation likely

Relative Strength

59 / 100
Slightly ahead

Debt / Equity

0.05
Debt-free

Business Description

Founded in 2016 and based in Beijing, Mega Genomics Limited provides genetic testing services to consumers and healthcare facilities across China. The company offers a broad range of tests covering cancer risk, brain health, heart disease, and hereditary conditions, as well as full genome and exome sequencing that can inform individuals about disease risks, medication responses, and lifestyle factors. Its testing kits are supplied directly to hospitals and health checkup centers, making genetic insights accessible through established medical channels.

Key Fundamentals

EPS0.15
P/E47.17
ROE4.09
RPS2.05
ROIC10.14
ROA3.18
Interest Cover19.84
EBITDA, mln54.40
EV / EBITDA20.51
EV / EBIT30.54
Revenue, mln401
EV / Revenue2.78

Quote Details

Last 7.08
Change 0.12 (1.72%)
Open 7.12
Volume 4,400
Turnover 31,152
Average Volume 111,419

Financial Ratios

Pre-Tax Profit Margin9
Leverage Ratio1.37
Current Ratio3.56
Price / Book2.05
Price / Tangible Book2.05
Price / Cash Flow1,300
Price / Free Cash Flow390
Debt / Equity0.05
Price / Sales3.72

Financial Strength

Altman Z-Score5.33
Piotroski F-Score 4 / 9
Beneish M-Score-1.09
Price to Intrinsic Value1.32
Price to Graham Number2.15

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -0.56% 56 / 100   
1 Month -0.56% 73 / 100   
2 Months -0.28% 68 / 100   
6 Months -0.7% 74 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog